Prospective heart valve treatment registry for TAVI patients
Part of Heart & circulation clinical trials.
This study is a real-world registry that collects information from people who receive TAVI, a procedure to treat a damaged heart valve. It may help doctors understand outcomes and improve care, even though it isn’t testing a new drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had the TAVI procedure (a catheter-based heart valve replacement/repair).
- You are being treated as part of routine care at participating centers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a patient registry that collects information from people who receive TAVI, a procedure used to treat certain heart valve problems. It may help doctors better understand who benefits and how patients do over time.
This registry collects information from adults who receive a less invasive heart valve procedure (done through a catheter). The goal is to learn how these treatments work in real-world patients and care over time.
This registry is for people with severe, symptomatic aortic valve narrowing who are planning a TAVI procedure (a less invasive valve replacement). It aims to better track and improve how patients do after the valve is replaced, based on how the procedure is planned and performed.
This is a registry study that tracks how people do after a TAVR procedure for a severely narrowed aortic heart valve. It helps doctors learn more about long-term outcomes and improve care for future patients.
This study tracks patients getting a new heart valve (transcatheter aortic valve implantation) for severe aortic stenosis. It aims to understand long-term outcomes and safety in a real-world registry.
This study is tracking how well the Myval valve works in people with severe aortic stenosis who get it through a minimally invasive procedure called TAVI. It helps doctors learn more about the valve's safety and performance in real-world use.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.